Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24670
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVairaktaris, E.en
dc.contributor.authorYapijakis, C.en
dc.contributor.authorNkenke, E.en
dc.contributor.authorVassiliou, S.en
dc.contributor.authorVylliotis, A.en
dc.contributor.authorNixon, A. M.en
dc.contributor.authorDerka, S.en
dc.contributor.authorRagos, V.en
dc.contributor.authorSpyridonidou, S.en
dc.contributor.authorTsigris, C.en
dc.contributor.authorNeukam, F. W.en
dc.contributor.authorPatsouris, E.en
dc.date.accessioned2015-11-24T19:42:38Z-
dc.date.available2015-11-24T19:42:38Z-
dc.identifier.issn0361-8609-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24670-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectCarboxypeptidase U/*geneticsen
dc.subjectCarcinoma, Squamous Cell/*geneticsen
dc.subjectCase-Control Studiesen
dc.subjectFemaleen
dc.subjectGene Frequencyen
dc.subject*Genetic Predisposition to Diseaseen
dc.subjectGermanyen
dc.subjectGreeceen
dc.subjectHomozygoteen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectMouth Neoplasms/*geneticsen
dc.subjectPolymorphism, Single Nucleotide/*geneticsen
dc.titleThe 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral canceren
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1002/ajh.20985-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17636471-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1002/ajh.20985/asset/20985_ftp.pdf?v=1&t=h0atvxln&s=71caa113aec971d022dddc814abf1874ce031163-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractNo studies thus far have investigated the contribution of thrombin activatable fibrinolysis inhibitor (TAFI) to oral oncogenesis. We studied the activity-related 1040C/T polymorphism in 150 patients with oral cancer and 138 healthy controls matched by age, gender, and ethnicity. The increased-activity T allele frequency was significantly reduced in patients compared with controls (28.7% vs. 37.0%, P < 0.05). T/T homozygotes had about half the probability of developing oral cancer (O.R. 0.39, 95%C.I. 0.13-1.14), while no significant difference was observed in C/T heterozygotes. The observed prophylactic effect of increased TAFI activity might result from reduction of plasmin and inhibition of extracellular matrix dissolution.en
heal.journalNameAm J Hematolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Vairaktaris-2007-The 1040C_T polymorp.pdf99.87 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons